ArticleJournal for immunotherapy of cancer2026

PGE2-mediated NK cell reprogramming drives acquired immunotherapy resistance in lung adenocarcinoma.

Yajing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.